Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.019 EUR | +0.99% | -2.77% | -1.16% |
Mar. 14 | Pharming Group N.V. Provides Earnings Guidance for the Year 2024 | CI |
Mar. 14 | Pharming Group Seeks Acquisitions | CI |
Sales 2023 | 224M 242M | Sales 2024 * | 262M 283M | Capitalization | 677M 730M |
---|---|---|---|---|---|
Net income 2023 | -9M -9.7M | Net income 2024 * | 1M 1.08M | EV / Sales 2023 | 3.08 x |
Net cash position 2023 * | 75.42M 81.31M | Net cash position 2024 * | 90.86M 97.96M | EV / Sales 2024 * | 2.24 x |
P/E ratio 2023 * |
-112
x | P/E ratio 2024 * |
-336
x | Employees | 332 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.91% |
Latest transcript on Pharming Group N.V.
1 day | +0.69% | ||
1 week | -3.05% | ||
Current month | -1.36% | ||
1 month | -2.78% | ||
3 months | -2.87% | ||
6 months | -14.41% | ||
Current year | -1.45% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Director of Finance/CFO | 55 | 20-11-15 | |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 61 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.05% | 7 M€ | -.--% | - | |
0.02% | 735 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.019 | +0.99% | 5 288 758 |
24-03-27 | 1.009 | -0.30% | 7,513,826 |
24-03-26 | 1.012 | -1.84% | 6,155,152 |
24-03-25 | 1.031 | -1.06% | 3,303,648 |
24-03-22 | 1.042 | -0.57% | 8,267,003 |
Real-time Euronext Amsterdam, March 28, 2024 at 05:52 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.45% | 733M | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.72% | 210B | |
+1.34% | 210B | |
-6.91% | 201B | |
-3.51% | 157B |